Streetbeat News

Regulatory

SONN

Sonnet BioTherapeutics has released a virtual investor segment discussing their recent U.S. patent issuance for a variant of IL-18, which is incorporated into their novel immunotherapeutic drug candidates, SON-1400 and SON-1411.

Portfolio Pulse from

November 12, 2024 | 2:30 pm

XOM

Exxon CEO Darren Woods advocates for the U.S. to remain involved in global climate change efforts, despite President-elect Donald Trump's previous withdrawal from the Paris climate agreement.

Portfolio Pulse from

November 12, 2024 | 2:30 pm

CVKD

Cadrenal Therapeutics presented tecarfarin data and a clinical trial protocol at the EACTS Medical Congress, focusing on its use in patients with the Abbott HeartMate3 LVAD.

Portfolio Pulse from

November 12, 2024 | 2:15 pm

SILS

Silver Scott Health, a division of Silver Scott Mines, Inc. (OTC PINK:SILS), anticipates significant opportunities in healthcare with the Trump Administration's potential overturning of the Affordable Healthcare Act.

Portfolio Pulse from

November 12, 2024 | 2:15 pm

MIST

Milestone Pharmaceuticals has reported its third quarter 2024 financial results and provided updates on its regulatory and corporate activities. The New Drug Application (NDA) for CARDAMYST™ in paroxysmal supraventricular tachycardia (PSVT) is currently under review by the FDA, with a Prescription Drug User Fee Act (PDUFA) date set for March 27, 2025.

Portfolio Pulse from

November 12, 2024 | 2:15 pm

PHG

Philips has received FDA 510(k) clearance for its Spectral CT 7500 RT, a spectral 4DCT imaging system designed for radiation oncology. This advancement aims to enhance personalized cancer care by improving tumor visualization and treatment planning.

Portfolio Pulse from

November 12, 2024 | 2:15 pm

BDRX

Biodexa Pharmaceuticals PLC has regained compliance with Nasdaq's $1.00 minimum bid price requirement, ensuring its continued listing on the exchange.

Portfolio Pulse from

November 12, 2024 | 2:00 pm

PEGY

Pineapple Energy Inc. has regained compliance with Nasdaq's minimum bid price requirements, ensuring its continued listing on the Nasdaq Capital Market.

Portfolio Pulse from

November 12, 2024 | 2:00 pm

PLUG

Plug Power reported a larger-than-expected loss for the third quarter, and the potential impact of a new administration could lead to a less favorable environment for green energy companies.

Portfolio Pulse from

November 12, 2024 | 1:45 pm

PLTR

Mike Gallagher, head of defense at Palantir and former U.S. Congressman, discusses the need for an aggressive reform agenda for the next Defense Secretary. He also talks about the geopolitical threats facing President-elect Trump in his second term.

Portfolio Pulse from

November 12, 2024 | 1:45 pm